Menu

• Ask a Health Expert about BONE DEVELOPMENT ABNORMAL
• Post Your Side Effect related to BONE DEVELOPMENT ABNORMAL
• BONE DEVELOPMENT ABNORMAL and FDA Warnings
• BONE DEVELOPMENT ABNORMAL in Patients Wiki
• Report BONE DEVELOPMENT ABNORMAL in Drug Side Effect Survey

BONE DEVELOPMENT ABNORMAL side effect

What is BONE DEVELOPMENT ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Rebif Side Effects Report #5670506-6
Physician from UNITED STATES reported REBIF problem on Mar 03, 2008. Male patient, weighting 6.10 lb, was diagnosed with multiple sclerosis, pain, incontinence, fatigue, blood cholesterol increased, diabetes mellitus and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, caesarean section, congenital anomaly, congenital scoliosis, cyanosis neonatal, foetal malnutrition, premature baby, pulmonary hypoplasia, . REBIF dosage: unknown. During the same period patient was treated with NEURONTIN, DITROPAN, PROVIGIL, CRESTOR, GLUCOVANCE. Patient died on 12/26/2004.

Trileptal Side Effects Report #5633561-5
TRILEPTAL problem was reported by a Physician from AUSTRALIA on Feb 18, 2008. Female patient, child 8 years of age, was diagnosed with epilepsy and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, . TRILEPTAL dosage: unknown. Patient recovered.

Zometa Side Effects Report #5586365-6
Health Professional from GERMANY reported ZOMETA problem on Jan 09, 2008. Female patient, 73 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma, pain and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, breath odour, dental treatment, endotracheal intubation, open wound, oral surgery, osteonecrosis, purulence, sequestrectomy, . ZOMETA dosage: 4 MG, QD. During the same period patient was treated with FENTANYL, VINCRISTINE. Patient was hospitalized. Patient recovered.

Trileptal Side Effects Report #5532742-9
TRILEPTAL problem was reported by a Physician from AUSTRALIA on Nov 26, 2007. Female patient, child 7 years of age, was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, precocious puberty, . TRILEPTAL dosage: 20MG/KG, 300MG BD. Patient recovered.


Lamictal Side Effects Report #5537387-2
Physician from FRANCE reported LAMICTAL problem on Nov 28, 2007. Male patient, weighting 5.51 lb, was diagnosed with epilepsy, prophylaxis and was treated with LAMICTAL. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, cardiac arrest, cardiopulmonary failure, emphysema, lymphangiectasia, multi-organ failure, pleural effusion, pulmonary hypoplasia, . LAMICTAL dosage: 100MG PER DAY. During the same period patient was treated with SPECIAFOLDINE. Patient died on 08/21/2006.

Trileptal Side Effects Report #5522993-1
TRILEPTAL problem was reported by a Physician from AUSTRALIA on Nov 14, 2007. Female patient, child 8 years of age, was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, precocious puberty, . TRILEPTAL dosage: unknown. Patient recovered.

Keppra Side Effects Report #5528539-6
Physician from FRANCE reported KEPPRA problem on Nov 07, 2007. Female patient, weighting 5.16 lb, was diagnosed with epilepsy, systemic lupus erythematosus and was treated with KEPPRA. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, caesarean section, cartilage development disorder, dysmorphism, neonatal disorder, placental disorder, therapeutic agent toxicity, . KEPPRA dosage: unknown. During the same period patient was treated with TRILEPTAL, PLAQUENIL, PARACETAMOL, PREDNISONE, ACTONEL, OROCAL D, DIFFU, SPECIAFOLDINE. Patient recovered.

Copegus Side Effects Report #5445008-2
COPEGUS problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 29, 2007. Female patient, 29 years of age, weighting 175.0 lb, was diagnosed with hepatitis c, depression, nausea and was treated with COPEGUS. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, bone metabolism disorder, cerebral ventricle dilatation, cystic lymphangioma, ill-defined disorder, skin oedema, ultrasound antenatal screen, . COPEGUS dosage: unknown. During the same period patient was treated with PEGASYS, EFFEXOR, COMPAZINE. Patient recovered.

Zometa Side Effects Report #5293063-5
Physician from GERMANY reported ZOMETA problem on Mar 30, 2007. Female patient, 73 years of age, weighting 156.5 lb, was diagnosed with multiple myeloma, pain and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone development abnormal, dental treatment, osteonecrosis, sequestrectomy, . ZOMETA dosage: 4 MG, QD. During the same period patient was treated with FENTANYL, VINCRISTINE. Patient recovered.


Zometa Side Effects Report #5648463-8
ZOMETA problem was reported by a Physician from DENMARK on Feb 25, 2008. Female patient, 55 years of age, weighting 176.4 lb, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: abscess jaw, bone development abnormal, bone disorder, bone trimming, dental prosthesis placement, dry mouth, eating disorder, excessive granulation tissue, fistula, . ZOMETA dosage: 4 MG, EVERY THREE WEEKS. During the same period patient was treated with OXYCONTIN, AKARIN, TOLVON, FORTAMOL, ANTINEOPLASTIC AGENTS, ANTINEOPLASTIC AGENTS. Patient was hospitalized and became disabled. Patient recovered.

Zometa Side Effects Report #5703746-8
Consumer or non-health professional from FRANCE reported ZOMETA problem on Apr 04, 2008. Female patient, 58 years of age, was diagnosed with multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone development abnormal, open wound, oral surgery, osteitis, osteonecrosis, osteosclerosis, tooth disorder, tooth loss, . ZOMETA dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Zometa Side Effects Report #5703670-0
ZOMETA problem was reported by a Consumer or non-health professional from FRANCE on Apr 04, 2008. Female patient, 61 years of age, was diagnosed with metastases to bone and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone density decreased, bone development abnormal, bone disorder, computerised tomogram abnormal, osteonecrosis, osteosclerosis, tooth disorder, tooth extraction, . ZOMETA dosage: unknown. Patient was hospitalized. Patient recovered.